Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-30 @ 1:32 PM
Study NCT ID:
NCT01385657
Status:
COMPLETED
Last Update Posted:
2020-02-26
First Post:
2011-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2012-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-09
First Submit QC Date:
None
Study First Post Date:
2011-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-24
Last Update Post Date:
2020-02-26
Last Update Post Date Type:
ACTUAL